These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34576091)

  • 1. Establishment of an Adult Medaka Fatty Liver Model by Administration of a Gubra-Amylin-Nonalcoholic Steatohepatitis Diet Containing High Levels of Palmitic Acid and Fructose.
    Fujisawa K; Takami T; Okubo S; Nishimura Y; Yamada Y; Kondo K; Matsumoto T; Yamamoto N; Sakaida I
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source.
    Boland ML; Oró D; Tølbøl KS; Thrane ST; Nielsen JC; Cohen TS; Tabor DE; Fernandes F; Tovchigrechko A; Veidal SS; Warrener P; Sellman BR; Jelsing J; Feigh M; Vrang N; Trevaskis JL; Hansen HH
    World J Gastroenterol; 2019 Sep; 25(33):4904-4920. PubMed ID: 31543682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a novel selective PPARα modulator, statin, sodium-glucose cotransporter 2 inhibitor, and combinatorial therapy on the liver and vasculature of medaka nonalcoholic steatohepatitis model.
    Kimura A; Kamimura K; Ohkoshi-Yamada M; Shinagawa-Kobayashi Y; Goto R; Owaki T; Oda C; Shibata O; Morita S; Sakai N; Abe H; Yokoo T; Sakamaki A; Kamimura H; Terai S
    Biochem Biophys Res Commun; 2022 Mar; 596():76-82. PubMed ID: 35121372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
    Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    World J Gastroenterol; 2016 Mar; 22(10):2931-48. PubMed ID: 26973390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid attenuates high-fat diet-induced steatohepatitis
    Xin FZ; Zhao ZH; Zhang RN; Pan Q; Gong ZZ; Sun C; Fan JG
    World J Gastroenterol; 2020 May; 26(18):2203-2220. PubMed ID: 32476787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH.
    Baandrup Kristiansen MN; Veidal SS; Christoffersen C; Feigh M; Vrang N; Roth JD; Erickson M; Adorini L; Jelsing J
    BMC Gastroenterol; 2019 Dec; 19(1):228. PubMed ID: 31883514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.
    Schumacher-Petersen C; Christoffersen BØ; Kirk RK; Ludvigsen TP; Zois NE; Pedersen HD; Vyberg M; Olsen LH
    J Transl Med; 2019 Apr; 17(1):110. PubMed ID: 30943987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high fructose intake on liver injury progression in high fat diet induced fatty liver disease in ovariectomized female mice.
    Ohashi T; Kato M; Yamasaki A; Kuwano A; Suzuki H; Kohjima M; Ogawa Y
    Food Chem Toxicol; 2018 Aug; 118():190-197. PubMed ID: 29751074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis.
    Hansen HH; Ægidius HM; Oró D; Evers SS; Heebøll S; Eriksen PL; Thomsen KL; Bengtsson A; Veidal SS; Feigh M; Suppli MP; Knop FK; Grønbæk H; Miranda D; Trevaskis JL; Vrang N; Jelsing J; Rigbolt KTG
    BMC Gastroenterol; 2020 Jul; 20(1):210. PubMed ID: 32631250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model.
    Li H; Yoo W; Park HM; Lim SY; Shin DH; Kim S; Park HY; Jeong TS
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease.
    Yueh MF; He F; Chen C; Vu C; Tripathi A; Knight R; Karin M; Chen S; Tukey RH
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31259-31266. PubMed ID: 33229553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method to induce nonalcoholic steatohepatitis (NASH) in mice.
    Savari F; Mard SA; Badavi M; Rezaie A; Gharib-Naseri MK
    BMC Gastroenterol; 2019 Jul; 19(1):125. PubMed ID: 31307427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
    Lee H; Ahn J; Shin SS; Yoon M
    Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.
    Svop Jensen V; Fledelius C; Max Wulff E; Lykkesfeldt J; Hvid H
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
    Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
    World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat "Western-type" diet in mice.
    Jurado-Ruiz E; Varela LM; Luque A; Berná G; Cahuana G; Martinez-Force E; Gallego-Durán R; Soria B; de Roos B; Romero Gómez M; Martín F
    Mol Nutr Food Res; 2017 Mar; 61(3):. PubMed ID: 27749006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.